Endovascular Treatment Showing Promising Short-Term Results in Patients with Total Bilateral Aortoiliac Occlusion

Moeini, Majid; Najafabadi, Borna Tadayon; Zafarghandi, Mohammadreza; Salimi, Javad; Taghavi, Morteza; Hassani, Mohammad; Noaparast, Morteza

doi:10.5812/iranjradiol.61843

Cited by 1 publication

(1 citation statement)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Transatlantic inter-society consensus (TASC II) for the management of peripheral arterial disease classifies infrarenal aorto-iliac occlusion, unilateral occlusion of both common iliac and external iliac, bilateral external iliac occlusion and unilateral common iliac, external iliac and common femoral diffuse stenosis as type D lesions. For such lesions, the traditional recommendation is open surgical procedure (bypass graft) (6) with a patency rate of 87.5% and 81.8% at 5 and 10 years, but with mortality and morbidity rate of 3.3% and 8.3% respectively (7). However, use of endovascular treatment for such lesions is not uncommon as many patients who need the intervention do not meet the criteria for surgery (8).…”

Section: Introductionmentioning

confidence: 99%

Study of endovascular treatment in obstructive aortoiliac lesions: Immediate and short-term results

Joshi¹,

Madan²,

Charaniya³

et al. 2021

HVT

View full text Add to dashboard Cite

Objective: Aorto-iliac occlusive disease (AIOD) is a common atherosclerotic disease causing significant morbidity. Transatlantic intersociety consensus for the management of peripheral arterial disease (TASC II) recommends endovascular therapy (ET) for better management of patients with lesions type A and B. With the advent of endovascular therapy, type C and D lesions management is becoming more feasible with endovascular therapy than open surgery for aorto-iliac occlusive disease. We aimed to evaluate patients with AOID and to describe short-term outcome of endovascular treatment for such lesions. Methods: Patients with aorto-iliac occlusive diseases who underwent endovascular therapy were enrolled in the study. Their demographic data and risk factors were recorded. Patients were followed at 3 and 6 months and their primary patency rate and symptom status were recorded. Results: We enrolled 100 patients with a mean age of 59.77 (8.75) years with the majority of patients being male. The most common presentation was claudication (59%) followed by rest pain (31%) and gangrene (20%). The majority of patients had Transatlantic inter-society consensus (TASC) II type A (44%) and type B (31%) lesions; 15% of patients had types C lesions and the remaining 10% patients had type D lesions. Access site hematoma and contrast-induced nephropathy were present in 7% and 5% of patients respectively. Stent patency rate was 97% and 95% at 3 and 6 months follow up respectively. Conclusion: Endovascular therapy in aorto-iliac occlusive disease is a safe, effective, and low-cost treatment option with a high patency rate and symptomatic improvement in the short-term.

show abstract

Section: Introductionmentioning

confidence: 99%